$5.52 Billion is the total value of PFM Health Sciences, LP's 72 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 229.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EEM | New | ISHARESmsci emg mkt etf | $438,918,000 | – | 10,702,700 | +100.0% | 7.96% | – |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $401,162,000 | +0.2% | 7,722,083 | +2.5% | 7.27% | -9.6% |
| GOOGL | Buy | GOOGLE INCcl a | $295,293,000 | +12.4% | 264,953 | +13.0% | 5.35% | +1.3% |
| HCA | Buy | HCA HOLDINGS INC | $250,101,000 | +46.5% | 4,763,828 | +33.1% | 4.53% | +32.1% |
| WAG | New | WALGREEN CO | $187,691,000 | – | 2,842,511 | +100.0% | 3.40% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $180,679,000 | – | 3,419,353 | +100.0% | 3.28% | – |
| ENDP | New | ENDO INTL PLC | $154,612,000 | – | 2,252,173 | +100.0% | 2.80% | – |
| HAL | New | HALLIBURTON CO | $143,386,000 | – | 2,434,807 | +100.0% | 2.60% | – |
| SCHW | New | SCHWAB CHARLES CORP NEW | $136,411,000 | – | 4,991,258 | +100.0% | 2.47% | – |
| FOXA | New | TWENTY FIRST CENTY FOX INCcl a | $128,605,000 | – | 4,022,685 | +100.0% | 2.33% | – |
| WDAY | Buy | WORKDAY INCcl a | $122,436,000 | +246.6% | 1,339,125 | +215.2% | 2.22% | +212.7% |
| TWC | New | TIME WARNER CABLE INC | $118,999,000 | – | 867,468 | +100.0% | 2.16% | – |
| VMC | New | VULCAN MATLS CO | $111,795,000 | – | 1,682,389 | +100.0% | 2.03% | – |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $106,748,000 | +1363.1% | 809,743 | +1202.9% | 1.94% | +1216.3% |
| WYNN | New | WYNN RESORTS LTD | $104,438,000 | – | 470,123 | +100.0% | 1.89% | – |
| AGN | Buy | ALLERGAN INC | $91,882,000 | +83.4% | 740,383 | +64.2% | 1.67% | +65.4% |
| MHFI | Buy | MCGRAW HILL FINL INC | $91,840,000 | +76.2% | 1,203,675 | +80.6% | 1.66% | +58.9% |
| YHOO | New | YAHOO INC | $88,917,000 | – | 2,476,788 | +100.0% | 1.61% | – |
| MCK | Buy | MCKESSON CORP | $85,825,000 | +354.0% | 486,067 | +315.0% | 1.56% | +309.5% |
| MLM | New | MARTIN MARIETTA MATLS INC | $83,846,000 | – | 653,261 | +100.0% | 1.52% | – |
| CBS | Buy | CBS CORP NEWcl b | $72,223,000 | +74.1% | 1,168,656 | +79.5% | 1.31% | +57.0% |
| LBTYK | New | LIBERTY GLOBAL PLC | $71,213,000 | – | 1,749,276 | +100.0% | 1.29% | – |
| NOW | New | SERVICENOW INC | $67,009,000 | – | 1,118,308 | +100.0% | 1.22% | – |
| TEX | New | TEREX CORP NEW | $65,883,000 | – | 1,487,208 | +100.0% | 1.19% | – |
| MIC | New | MACQUARIE INFRASTR CO LLCmembership int | $59,144,000 | – | 1,032,730 | +100.0% | 1.07% | – |
| PCLN | New | PRICELINE COM INC | $53,185,000 | – | 44,622 | +100.0% | 0.96% | – |
| AXP | New | AMERICAN EXPRESS CO | $52,477,000 | – | 582,882 | +100.0% | 0.95% | – |
| Buy | DENDREON CORPnote 2.875% 1/1 | $49,801,000 | +15.1% | 67,072,000 | +0.2% | 0.90% | +3.8% | |
| THC | Buy | TENET HEALTHCARE CORP | $49,773,000 | +26.3% | 1,162,648 | +24.3% | 0.90% | +13.9% |
| CTRP | New | CTRIP COM INTL LTD | $46,498,000 | – | 922,209 | +100.0% | 0.84% | – |
| KYTH | Buy | KYTHERA BIOPHARMACEUTICALS I | $39,899,000 | +28.4% | 1,003,492 | +20.6% | 0.72% | +15.7% |
| PFE | Buy | PFIZER INC | $38,765,000 | +51.6% | 1,206,879 | +44.5% | 0.70% | +36.8% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $38,038,000 | – | 1,563,435 | +100.0% | 0.69% | – |
| HUM | Buy | HUMANA INC | $37,466,000 | +174.1% | 332,383 | +151.0% | 0.68% | +146.9% |
| RAD | New | RITE AID CORP | $36,209,000 | – | 5,774,926 | +100.0% | 0.66% | – |
| EXPE | New | EXPEDIA INC DEL | $35,120,000 | – | 484,412 | +100.0% | 0.64% | – |
| OREX | Buy | OREXIGEN THERAPEUTICS INC | $33,339,000 | +17.3% | 5,129,129 | +1.6% | 0.60% | +5.8% |
| MOH | New | MOLINA HEALTHCARE INC | $29,226,000 | – | 778,117 | +100.0% | 0.53% | – |
| YELP | New | YELP INCcl a | $27,942,000 | – | 363,207 | +100.0% | 0.51% | – |
| DATA | New | TABLEAU SOFTWARE INCcl a | $27,674,000 | – | 363,753 | +100.0% | 0.50% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $27,432,000 | – | 723,621 | +100.0% | 0.50% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $21,954,000 | – | 66,571 | +100.0% | 0.40% | – |
| PRTA | New | PROTHENA CORP PLC | $20,763,000 | – | 541,983 | +100.0% | 0.38% | – |
| APC | New | ANADARKO PETE CORP | $18,040,000 | – | 212,833 | +100.0% | 0.33% | – |
| OCR | Buy | OMNICARE INC | $15,811,000 | +112.2% | 264,968 | +114.7% | 0.29% | +91.3% |
| TXMD | New | THERAPEUTICSMD INC | $15,243,000 | – | 2,415,733 | +100.0% | 0.28% | – |
| CI | New | CIGNA CORPORATION | $14,202,000 | – | 169,613 | +100.0% | 0.26% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $10,108,000 | – | 320,903 | +100.0% | 0.18% | – |
| FRX | New | FOREST LABS INC | $7,661,000 | – | 83,033 | +100.0% | 0.14% | – |
| MGNX | Buy | MACROGENICS INC | $5,822,000 | +150.2% | 209,212 | +146.6% | 0.11% | +125.5% |
| CX | New | CEMEX SAB DE CVspon adr new | $5,665,000 | – | 448,556 | +100.0% | 0.10% | – |
| PKI | New | PERKINELMER INC | $5,248,000 | – | 116,477 | +100.0% | 0.10% | – |
| CLDN | New | CELLADON CORP | $4,591,000 | – | 385,110 | +100.0% | 0.08% | – |
| CSLT | New | CASTLIGHT HEALTH INCcl b | $2,042,000 | – | 96,223 | +100.0% | 0.04% | – |
| SAVE | New | SPIRIT AIRLS INC | $1,144,000 | – | 19,264 | +100.0% | 0.02% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $570,000 | – | 404,100 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.